Clinical Trial Update: Safety Study of a Vaccine to Help Protect Against Lyme Disease in Healthy Children [Phase 3]

View source ↗

Summary

Pfizer conducted a Phase 3 safety study of a Lyme disease vaccine in healthy children; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lyme Disease

Drugs mentioned

• Lyme disease vaccine (Pfizer)

Snippet

Sponsor: Pfizer | Conditions: Lyme Disease | Phase 3 | Status: COMPLETED